Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_provenance.
- NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_assertion description "[In conclusion, alpha-fetoprotein-derived peptide appears to be a novel agent that interferes with the growth of tamoxifen-sensitive as well as tamoxifen-resistant estrogen-receptor-positive human breast cancers; it inhibits the uterotrophic side effect of tamoxifen and, thus, it may be useful in combination with or in place of tamoxifen for treatment of estrogen-receptor-positive human breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_provenance.
- NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_assertion evidence source_evidence_literature NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_provenance.
- NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_assertion SIO_000772 11830647 NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_provenance.
- NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_assertion wasDerivedFrom befree-2016 NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_provenance.
- NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_assertion wasGeneratedBy ECO_0000203 NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_provenance.
- befree-2016 importedOn "2016-02-19" NP344235.RAbz2A-80oaT5Xf6AaYvd1FJmNTOjXZ8zR0fvUtBahBIc130_provenance.